ABSTRACT
Background Acute kidney injury (AKI) is common among children with critical illness and is associated with high morbidity and mortality. Risk prediction models designed for clinical decision support implementation offer an opportunity to identify and proactively mitigate AKI risks. Existing models have been primarily validated on single-center data, owing partly to the lack of appropriately detailed multicenter datasets.
Objective To determine the accuracy of a single-center model to predict new AKI at 72 hours of ICU admission across two multicenter datasets and extend this model to improve prediction accuracy while maintaining acceptable alert burden.
Derivation and Validation Cohorts We separately derived models in two datasets: PEDSNET-VPS, created through the linkage of PEDSnet electronic health record (EHR) extraction with Virtual Pediatric Systems (VPS); and the PICU Data Collaborative dataset, created through EHR extraction and harmonization from eight participating institutions. Derivation datasets comprised temporal and location-specific spit of these datasets (80%), while the holdout test split comprised the remaining (20%).
Prediction Model We recalibrated an existing single-center model and measured discrimination and accuracy. We then add features guided by precision and recall measures. All features were available at 12 hours of ICU admission. We measure discrimination and accuracy at multiple cut-points and identify the features contributing most to the risk score.
Results In two datasets comprising 186,540 ICU admissions, we report an incidence of early AKI of 2.2 – 2.7%. Initial recalibration of an existing single-center model demonstrated poor discrimination (AUROC 0.60 – 0.78). Following the addition of new features, we report higher AUROC values of 0.79 - 0.80 and AUPRC values of 0.13 – 0.21 in both datasets. We report accuracy at several cutpoints as well as cross-validate between datasets.
Conclusions In this first use of two new multicenter datasets, we report improved discrimination and accuracy in a model designed specifically for implementation, balancing sensitivity and precision to predict patients at risk for AKI development.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the NIH NIDDK K23DK138299. The PICU Data Collaborative is supported in part by the Laura P. and Leland K. Whittier Virtual Pediatric Intensive Care Unit.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Children's Hospital of Philadelphia waived ethical approval for this work [specific to PEDSNET-VPS dataset]. Ethics committee/IRB of the University of Rochester gave ethical approval for this work [specific to PDC dataset].
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.